InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (2 ops.)
Insider track record
CEODisclosed buys
2
Disclosed sells
2
T+90 hit rate
0%
T+90 mean return
-15.5%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Dubensky Thomas W., Chairman & CEO. Insider active across 3 companies, notably Millendo Therapeutics, Inc.. In total, 8 filings have been published. Breakdown: 2 buys · 2 sells. Total volume traded: €17k. History available since 7 January 2022. The latest transaction was filed on 7 January 2022 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations8 total
2,000 shares@ US$4.780.031% mcap50.0% of flowCommon StockSEC:0001209191-22-002963:0
Ideal exit: 4 Oct 2022 (T+270)
2,000 shares@ US$4.7850.0% of flowCommon StockSEC:0001209191-22-002963
Ideal exit: 4 Oct 2022 (T+270)
111,343 sharesCommon StockSEC:0001140361-21-022784:0
111,343 sharesCommon StockSEC:0001140361-21-022784
6,932 sharesCommon StockSEC:0001209191-16-090068:0
8,068 sharesCommon StockSEC:0001209191-16-090068:1
11,229 sharesCommon StockSEC:0001209191-16-090068:2
3,771 sharesCommon StockSEC:0001209191-16-090068:3
8 of 8 declarations
About Dubensky Thomas W.
Dubensky Thomas W. is the Chief Executive Officer of Millendo Therapeutics, Inc. and Tempest Therapeutics, Inc. As a leader, he is responsible for defining the strategic vision and overseeing the daily operations of the companies. His experience in the biopharmaceutical sector enables him to lead innovative initiatives and promote the development of new treatments. Under his leadership, the companies strive to improve patients' lives through advanced therapeutic solutions.
